Internal Medicine, Infectious Disease · Newark, NJ
NPI
1366530982
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
140 Bergen St, Acc Level D
Newark, NJ, 07103
Phone (973) 972-4071
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,857
83 services
Medicare patients, 2024
56
Average age 67
Drug cost, 2024
$2.0M
2,402 prescriptions
Company payments, 2025
$123
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debra Chew was code 99232 (hospital e&m - subsequent), 27 times for 19 patients. In total Debra Chew billed 83 services in 4 codes, and Medicare paid $7,857.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 27 | 19 | $66.83 | $1,804 |
| 99214 Office E&M - Established | Facility | 25 | 16 | $69.88 | $1,747 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $147.06 | $3,529 |
By year: 2022 $5,106 for 60 services; 2023 $5,884 for 72 services; 2024 $7,857 for 83 services.
Medicare prescription drug claims, 2024
In 2024, the drug Debra Chew prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 284 prescriptions and refills. In total Debra Chew wrote 2,402 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 284 | 288 | 35 | $1.1M |
| Atorvastatin Calcium Generic | 149 | 281 | 36 | $776 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 101 | 103 | 18 | $1,647 |
| Ritonavir Generic | 95 | 101 | Under 11 | $7,721 |
| Tivicay Dolutegravir Sodium | 85 | 85 | 11 | $192K |
| Darunavir Generic | 81 | 81 | Under 11 | $101K |
| Losartan Potassium Generic | 68 | 135 | 16 | $255 |
| Atovaquone Generic | 61 | 61 | Under 11 | $33K |
| Ibuprofen Generic | 49 | 49 | Under 11 | $156 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 48 | 48 | Under 11 | $179K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 56 | Under 11 | $342 |
| Nifedipine Er Nifedipine | 47 | 73 | Under 11 | $880 |
| Amlodipine Besylate Generic | 45 | 96 | 14 | $336 |
| Gabapentin Generic | 39 | 57 | Under 11 | $383 |
| Diclofenac Sodium Generic | 31 | 31 | Under 11 | $334 |
Brand drugs: 802 claims; generic drugs: 1,547 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debra Chew $123 ($123 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $97.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.